Maryland lawmakers in the state house and senate have introduced companion bills that would prohibit drugmaker 340B contract pharmacy restrictions [...] …
Category: Providers
Major hospital groups last week urged the U.S. Supreme Court to review a federal appeals court decision that upheld how [...] …
Several national hospital groups name 340B contract pharmacy protections, among other 340B goals, in their 2024 advocacy priorities. The American [...] …
Lobbying on 340B issues reached a record level in 2023, according to annual tallies of congressional lobbying disclosures. That flurry [...] …
A federal district judge last week denied two community health centers’ antitrust claims against four major diabetes drug manufacturers over [...] …
Eight Mississippi state senators have introduced a bill to bar drugmakers from restricting 340B contract pharmacy use and pharmacy benefit [...] …
A California hospital last week reached a settlement to pay the state of California and the U.S. government a combined [...] …
After more than six months of long meetings with stakeholders, a bipartisan group of six senators released draft legislation Friday [...] …
A recent federal district court ruling on the 340B patient definition created a “gray area” for 340B providers and drugmakers, [...] …
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...] …